ammoxetine hydrochloride
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 16, 2025
The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
(clinicaltrials.gov)
- P3 | N=770 | Not yet recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P3 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
March 09, 2023
The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
(clinicaltrials.gov)
- P2 | N=240 | Not yet recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P2 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
November 12, 2021
Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
(clinicaltrials.gov)
- P2; N=240; Recruiting; Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
1 to 3
Of
3
Go to page
1